The U.S. Drug Enforcement Administration rejected a September request from Colorado officials to participate in the United States’ historic marijuana rescheduling process. That’s one example of the “bias” that should disqualify the agency from overseeing the hearings, according to claims made in a filing submitted Monday to the DEA’s chief administrative law judge, John Mulrooney II. […]
Anthony Coniglio (Courtesy photo) (This is a contributed guest column. To be considered as an MJBizDaily guest columnist, please submit your request here.) While 2024 brought its share of volatility, regulatory uncertainty and market pressures for the cannabis industry, this year offers potential opportunities alongside continued challenges. From a new administration in the White House, federal rescheduling developments […]
Despite these challenges, support for marijuana legalization remains robust, with 68 percent of Americans backing reforms—a 20-point increase over the past decade, according to Gallup data. This enduring support underscores the complex reality of cannabis reform in the U.S., where cultural acceptance often outpaces legislative momentum. A Decade of Progress, but Challenges Persist As legalization […]
The Daily Hit is a recap of the top financial news stories for Thursday, December 5, 2024. On the Site Marijuana companies face skeptical appeals court in commerce challenge A crew of cannabis operators seeking to limit federal oversight of state-licensed marijuana businesses encountered sharp questioning from federal appeals court judges, who expressed doubt about arguments […]
The Drug Enforcement Administration’s (DEA) administrative law tribunal’s preliminary hearing gets underway today on the U.S. Department of Justice’s proposal to reschedule cannabis. It starts under a cloud of allegations regarding the agency’s bias towards anti-cannabis factions. Chief Administrative Law Judge John Mulrooney II of the DEA is leading the hearing. Mulrooney has attempted to […]
Every party that applied to argue against moving marijuana to Schedule 3 of the Controlled Substances Act has full standing to participate in an upcoming landmark hearing, a top U.S. Drug Enforcement Administration judge ruled late Tuesday. But only one organization supporting marijuana rescheduling will have full standing for the highly anticipated Dec. 2 hearing, […]
The U.S. Drug Enforcement Administration could allow more participants to testify at upcoming hearings concerning marijuana rescheduling in addition to the initial 25 who were designated in October. That’s according to a footnote in a Nov. 15 order, in which DEA Chief Administrative Law Judge John Mulrooney II rejected a veterans advocacy group’s attempt to […]
A hearing including the testimony of witnesses won’t happen until January or February 2025. The much-anticipated hearing for the rescheduling of cannabis has been delayed after the Chief Administrative Law Judge (ALJ) John Mulrooney issued a preliminary order on Thursday finding fault with the Drug Enforcement Administration’s (DEA) list of witnesses. First reported by Marijuana […]
The U.S. Drug Enforcement Administration has contacted 25 “designated participants” to testify at a Dec. 2 hearing about marijuana rescheduling, according to documents obtained by MJBizDaily. Before marijuana can be moved from Schedule 1 to Schedule 3 of the Controlled Substances Act, DEA Administrator Anne Milgram ordered that the matter go before an administrative law judge. […]
